From 2014 to 2016, PATH coordinated pilot introduction of the injectable contraceptive subcutaneous DMPA (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda. These materials feature guidance for monitoring DMPA-SC introductions, monitoring results, and lessons learned, which can help inform contraceptive introduction programming for DMPA-SC and other methods. For more information, please visit our subcutaneous DMPA (Sayana Press) introduction and research page.

Publication date: March 2018

Region: Africa, Global

PATH and its partners are in the early stages of developing microarray patches (MAPs) containing cabotegravir for HIV pre-exposure prophylaxis (PrEP), as well as a MAP containing cabotegravir and a contraceptive—a multipurpose protection technology (MPT).

Publication date: February 2018

Region: Global

This document was created to support ministry of health and nongovernmental partners as they develop strategies to introduce and scale up subcutaneous DMPA (DMPA-SC, brand name Sayana® Press) to increase contraceptive options and access. Available in English and French, the publication provides practical guidance based on results, evidence, and learning from the pilot introductions of Sayana Press in four countries in Africa. For more information, visit PATH's Reproductive Health Global Program website.

Publication date: January 2018

Region: Global

Subcutaneous DMPA (DMPA-SC, Sayana® Press) is a new, easy-to-use injectable contraceptive that is ideally suited for remote access and even self-injection. This brief provides an overview of PATH’s research studies assessing the feasibility and acceptability of self-injection in Uganda and Senegal. For more information, please visit our Reproductive Health Global Program website.

Publication date: January 2018

Region: Global

Part of series: Sayana Press (DMPA-SC in Uniject) introduction and research fact sheets

Subcutaneous DMPA is an innovative injectable contraceptive that can dramatically expand access and choice for women. A new initiative led by PATH and John Snow Inc., the Subcutaneous DMPA Access Collaborative is working with ministries of health and partners across sectors to strengthen scale-up and build toward a robust global market for the product. For more information, visit http://sites.path.org/rh/?p=292.

Publication date: January 2018

Region: Global

PATH’s Scale-Up project works to expand the use of human papillomavirus (HPV) testing for cervical cancer prevention. Based on PATH’s experience implementing the careHPV™ test in Central America, this manual, available in Spanish and English, provides guidance for organizing a quality assurance program to screening programs adopting the careHPV test.

Publication date: November 2017

Region: Latin America, Global

Women’s ownership of their sexual and reproductive health (SRH) is a rights-based expression of self-determination. In this issue of Outlook on Reproductive Health, we address these rights and highlight recent information on technologies and practices with high potential to enable and expand SRH self-care, including self-administration of injectable contraception, pericoital or “on-demand” contraception, safe practice of medical abortion at home, self-testing for HIV, and vaginal self-sampling for cervical cancer screening. The available evidence demonstrates that health systems and practitioners can and should trust women with many aspects of their own care.

Author: Murray M, Brady M, Drake J

Publication date: November 2017

Region: Global

Part of series: Outlook

Menstruation is a basic biological process for girls and women, yet many in India face challenges with managing menstruation, largely due to taboos and restrictions, including the availability and affordability of menstrual hygiene products and systems for safe disposal. This messaging framework provides overarching themes and talking points on menstrual hygiene management for most audiences. They put spokespersons and advocates on common ground so individuals and groups can echo and reinforce each other through their advocacy and outreach efforts.

Publication date: October 2017

Region: Asia

Subcutaneous DMPA (DMPA-SC, Sayana® Press) is a new, easy-to-use injectable contraceptive that is ideally suited for remote access and even self-injection. This brief provides an overview of PATH’s Self-Injection Best Practices project, which aims to evaluate and identify optimal program models for self-injection of DMPA-SC. For more information, please visit our Reproductive Health Global Program website.

Publication date: October 2017

Region: Global

Part of series: Sayana Press (DMPA-SC in Uniject) introduction and research fact sheets

Since the beginning of the pandemic, PATH has worked in more than 35 countries to reduce the global impact of HIV/AIDs. This fact sheet outlines the range of PATH’s work to address HIV/AIDS, from developing new diagnostics to improving service delivery.

Publication date: August 2017

Region: Global

This policy brief highlights the global burden of sexually transmitted infections (STI) on women and adolescent girls, and the need for advocates, implementers, funders, and governments to come together to address the neglected STI crisis to meet the Sustainable Development Goals and ensure a healthier life is in reach for women and adolescent girls worldwide.

Publication date: June 2017

Region: North America and Europe, Global

Advocacy for Better Health is a US Agency for International Development five-year, US$20 million project aimed at improving the availability, accessibility, and quality of health and social services in Uganda. Implemented by PATH and Initiatives Inc., the project aspires to engage communities in the planning and monitoring of health and social services, and enhance the capacity of civil society organizations to represent citizen interests and conduct advocacy to strengthen health-related policies, budgets, and programs.

Publication date: May 2017

Region: Africa

The series covers the three menstrual health themes—normalizing taboos, menstrual hygiene products (access, affordability, and appropriateness), and disposal systems and access to infrastructure in the Indian context.

Publication date: May 2017

Region: Asia

This fact sheet provides a comprehensive overview of Sayana® Press, a lower-dose formulation of the contraceptive Depo-Provera®. Sayana Press provides three months of contraceptive protection per dose, and is small, light, and requires minimal training to use—making it suitable for community-based distribution and administration through self-injection. For more information, please visit our Reproductive Health Global Program website.

Publication date: March 2017

Region: Africa

Part of series: Sayana Press (DMPA-SC in Uniject) introduction and research fact sheets

This brief provides a clinical overview of the injectable contraceptive Sayana® Press, which contains 30% less depot medroxyprogesterone acetate than the intramuscular presentation of Depo-Provera®. It is administered subcutaneously through the prefilled Uniject injection system, an autodisable injection device. For more information, please visit our Reproductive Health Global Program website.

Publication date: March 2017

Region: Africa

Part of series: Sayana Press (DMPA-SC in Uniject) introduction and research fact sheets

This brochure outlines PATH's work in Senegal. It describes our approach and outlines key areas of focus, including malaria elimination, strengthening health systems, responding to emerging health threats, improving reproductive health, and combatting noncommunicable diseases.

Publication date: January 2017

Region: Africa

Part of series: Country brochures

This brochure outlines PATH’s work to improve health in Uganda. Key areas of focus include cervical cancer prevention, detection, and treatment; vaccines and immunization, including supply chain improvements; advocacy to improve the quality and availability of health care services; and introduction of Sayana® Press, a popular new form of injectable contraceptive.

Publication date: January 2017

Region: Africa

Part of series: Country brochures

The contraceptive Sayana® Press, which is small, light, and requires minimal training to use, is suitable for community-based distribution as well as administration through self-injection. PATH and partners have coordinated country-led introductions of Sayana Press in sub-Saharan Africa and are conducting research on the impact of Sayana Press offered through a range of delivery channels, including self-injection. For more information, please visit our Reproductive Health Global Program website.

Publication date: January 2017

Region: Africa

Part of series: Sayana Press (DMPA-SC in Uniject) introduction and research fact sheets

In lower-income countries, women want to manage their fertility, but lack access to safe and effective contraception. PATH is working with the governments of Senegal and Uganda to research an option: self-injection of Sayana® Press. Results from the first study in Uganda indicate that most women can self-inject with training. For more information, please visit our Reproductive Health Global Program website.

Publication date: January 2017

Region: Africa

Part of series: Sayana Press (DMPA-SC in Uniject) introduction and research fact sheets

This website about PATH’s HIV/AIDS and Tuberculosis global program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2017

Region: Global

Part of series: Program websites